Archive for September 16th, 2020

Potential COVID-19 drug azithromycin may increase risk for cardiac events

Azithromycin — a commonly-prescribed antibiotic — also is being investigated as a potential treatment for COVID-19. Researchers have found that azithromycin by itself is not associated with an increase in cardiac events; however, if the drug is taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increased. Source: […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →

Factors inherent to obesity could increase vulnerability to COVID-19

Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, scientists say. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease. Source: […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →
Page 2 of 2 12